WO1994016691A1 - Nitroglycerine-containing plaster, process for producing the same and its use - Google Patents
Nitroglycerine-containing plaster, process for producing the same and its use Download PDFInfo
- Publication number
- WO1994016691A1 WO1994016691A1 PCT/EP1994/000053 EP9400053W WO9416691A1 WO 1994016691 A1 WO1994016691 A1 WO 1994016691A1 EP 9400053 W EP9400053 W EP 9400053W WO 9416691 A1 WO9416691 A1 WO 9416691A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- reservoir
- nitroglycerin
- active substance
- resins
- plaster according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
Definitions
- the invention relates to an active substance-containing plaster for the controlled release of nitroglycerin to human or animal skin with a backing layer which is impermeable to the nitroglycerin and a pressure-sensitive adhesive nitroglycerin in a uniform or uniform distribution containing a single or multi-layer reservoir, and the use thereof.
- Nitroglycerin patches are already known. The production of nitroglycerin patches is problematic in that nitroglycerin is explosive and, as a result, its evaporation and thermal and mechanical loads must be avoided as far as possible.
- nitroglycerin-containing pressure-sensitive adhesive layer often being produced from a solution.
- the known plaster-like transdermal therapeutic systems for delivering nitroglycerin produced in this way certainly fulfilled the therapeutic tasks, but are too expensive to manufacture.
- DE-OS 3222800 (ALZA) describes a nitroglycerin patch, the non-adhesive viscous mass obtainable at room temperature by thickening a nitroglycerin solution with a rheological agent being used as the nitroglycerin-containing matrix.
- US Pat. No. 3,742,951 (CIBA-GE GY), DP-PS 3315272 and DE-OS 3315245 (LOHMANN / SCHWARZ) also describe simply constructed nitroglycerin plasters with pressure-sensitive matrix materials prepared from solution at room temperature. It is also already known, for example from DE-OS 3642931 (CIBA-GEIGY), to use multi-part nitroglycerin reservoirs.
- Pressure-sensitive hot melt adhesives are generally known from EP-A2-175562; However, there is no suggestion as to whether and how these have to be selected for drug reservoirs, in particular those containing nitroglycerin.
- nitroglycerin plasters are described in EP-A 0204968, where a self-adhesive reservoir made of rubber and tackifying resin with nitroglycerin is used.
- This pressure-sensitive adhesive reservoir is produced from solution, so that here the problem of suctioning off solvent residues and possibly also the evaporation of nitroglycerin which occurs therewith occurs.
- the coating is associated with great difficulties because of the high viscosity of the coating composition. Due to the polymeric compounds contained in the nitroglycerin-containing adhesive (e.g. ethylene-vinyl acetate copolymers), the viscosity is so high that the production of the plasters containing nitroglycerin encounters extremely great problems.
- the polymeric compounds contained in the nitroglycerin-containing adhesive e.g. ethylene-vinyl acetate copolymers
- the solution to the problem is to obtain processable melts by using only resins, without using polymeric compounds.
- soft resins are tackifying resins which are semi-solid or liquid at room temperature or melt up to about 60 ° C. These include, for example, methyl esters of resin acids, methyl esters of hydrogenated resin acids, triethylene glycol esters of hydrogenated resin acids, hydroabietyl alcohol, phthalic acid esters of hydroabiety alcohol, aromatic hydrocarbon resins, low molecular weight styrene resins and hydrogenated hydrocarbon resins.
- Hard resins in the sense of the invention are tackifying resins which are solid at room temperature and soften from approx. 60 ° C.
- modified resin acids include modified resin acids, hydrogenated and non-hydrogenated resin esters, polymerized resin esters, acid-modified resin esters, aromatic and aliphatic hydrocarbon resins, alpha-methylstyrene resins, alpha-methylstyrene / vinyltoluene copolymer resins and hydrogenated hydrocarbon resins.
- the proportion of tackifying resins in the nitroglycer-containing adhesive is 10-43% by weight.
- the nitroglycerin-containing reservoir also contains plasticizers. Suitable plasticizers are known to the person skilled in the art and are described, for example, in DE-3743946.
- the nitroglycerin-containing reservoir usually contains plasticizers in a proportion of 0.1-5% by weight.
- Anti-aging agents in a concentration of 0.1 - 2 ⁇ & vr. -% contain. These are known to the person skilled in the art and e.g. described in DE-3743946.
- the materials for the impermeable backing layer and the removable protective layer are also known to the person skilled in the art (e.g. DE-3843239).
- a particularly preferred construction of the transdermal nitroglycerin plaster is the matrix system, in which, as is known, the matrix takes over the control for the release of the substance and this obeys the Higuchi Vt law. However, this does not mean that the membrane system is also indicated in special cases.
- a membrane controlling the release of nitroglycerin is attached between the reservoir and the pressure-sensitive adhesive layer. In the event that the reservoir is not sufficiently sticky to the skin, it can be provided with a layer of pressure-sensitive adhesive. In this way it is ensured that the transdermal patch adheres to the skin over the entire application period.
- the thickness of the transdermal patch depends on the therapeutic requirements and can be adapted accordingly. It is usually in the range of 0.03-0.4 mm.
- the production of the transdermal patch is particularly simple.
- the resins are melted, the remaining reservoir components are added at a temperature of less than 55 ° C. and homogenized by kneading or stirring.
- the result is reservoir masses with a viscosity of 1320 - 8253 dPa * s.
- the nitro-glycerol-containing reservoir mass obtained in this way is applied to the removable protective layer and the impermeable backing layer is laminated on.
- the machine required to manufacture the transdermal patch has only a small footprint and is significantly less expensive than conventional coating systems for processing solvent-based adhesives. It also works at a high speed in the range of approx. 10-50 m per minute. example 1
- plasticizer medium-chain triglycerides: Miglyol 812 from Dynamit Nobel
- nitroglycerin-lactose preparation (10% nitroglycerin) are added and homogenized by kneading.
- the reservoir mass obtained in this way (viscosity: 8253 dPa-s) is coated at 55 ° C. on the removable protective layer (Hostaphan RN 100 coated on one side with silicone (100 ⁇ thick) - from Kalle) in such a way that the reservoir with a basis weight of 175.5 g / m 2 results.
- the impermeable backing layer (Hostaphan RN 36 (36 ⁇ m thick) - from Kalle) is laminated on top.
- Example 3 The preparation is carried out as described in Example 1, but according to the preparation formula given in Table 1; Viscosity: 3301 dPas at 55 ° C).
- Example 3 The preparation is carried out as described in Example 1, but according to the preparation formula given in Table 1; Viscosity: 3301 dPas at 55 ° C).
- the preparation is carried out as indicated in Example 1, but according to the preparation formula given in Table 1 (viscosity: 1320 dPas at 55 ° C.).
- the active ingredient release of the 16 cm 2 transdermal patches is determined according to the rotating bottle method described in USP XXII in 0.9% saline solution at 37 ° C. The results are shown in Table 2.
Abstract
Description
Claims
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL94309602A PL174806B1 (en) | 1993-01-23 | 1994-01-10 | Nitroglycerin container plaster, method of obtaining same and application thereof |
EP94904650A EP0680319B1 (en) | 1993-01-23 | 1994-01-10 | Nitroglycerine-containing plaster, process for producing the same and its use |
JP6516613A JPH08505631A (en) | 1993-01-23 | 1994-01-10 | Method for producing plaster containing nitroglycerin and method of using the same |
AU58606/94A AU687775B2 (en) | 1993-01-23 | 1994-01-10 | Nitroglycerine-containing plaster, process for producing the same and its uses |
HU9501966A HU220768B1 (en) | 1993-01-23 | 1994-01-10 | Nitroglycerine-containing plaster and process for producing the same |
US08/492,004 US5670164A (en) | 1993-01-23 | 1994-01-10 | Nitroglycerin-containing patch, a process for the production and the use thereof |
DE59402070T DE59402070D1 (en) | 1993-01-23 | 1994-01-10 | PLASTER CONTAINING NITROGLYCER, METHOD FOR THE PRODUCTION AND USE THEREOF |
KR1019950703007A KR960700049A (en) | 1993-01-23 | 1994-01-10 | NITROGLYCERINE-CONTAINING PLASTER, PROCESS FOR PRODUCING THE SAME AND ITS USE |
SK891-95A SK279839B6 (en) | 1993-01-23 | 1994-01-10 | Plaster containing an active substance and process for producing the same |
NO952908A NO952908L (en) | 1993-01-23 | 1995-07-21 | Nitroglycerol-containing resin, method of preparation, and use of the resin |
FI953532A FI953532A0 (en) | 1993-01-23 | 1995-07-21 | Patches containing nitroglycerol, process for its preparation and its use |
GR970401155T GR3023505T3 (en) | 1993-01-23 | 1997-05-21 | Nitroglycerine-containing plaster, process for producing the same and its use. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4301781A DE4301781C2 (en) | 1993-01-23 | 1993-01-23 | Patch containing nitroglycerin, process for its production and use |
DEP4301781.9 | 1993-01-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1994016691A1 true WO1994016691A1 (en) | 1994-08-04 |
Family
ID=6478779
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1994/000053 WO1994016691A1 (en) | 1993-01-23 | 1994-01-10 | Nitroglycerine-containing plaster, process for producing the same and its use |
Country Status (26)
Country | Link |
---|---|
US (1) | US5670164A (en) |
EP (1) | EP0680319B1 (en) |
JP (1) | JPH08505631A (en) |
KR (1) | KR960700049A (en) |
AT (1) | ATE149829T1 (en) |
AU (1) | AU687775B2 (en) |
CA (1) | CA2153571A1 (en) |
CZ (1) | CZ284899B6 (en) |
DE (2) | DE4301781C2 (en) |
DK (1) | DK0680319T3 (en) |
ES (1) | ES2102199T3 (en) |
FI (1) | FI953532A0 (en) |
GR (1) | GR3023505T3 (en) |
HR (1) | HRP940030B1 (en) |
HU (1) | HU220768B1 (en) |
IL (1) | IL108233A (en) |
MY (1) | MY110391A (en) |
NO (1) | NO952908L (en) |
NZ (1) | NZ259710A (en) |
PH (1) | PH31559A (en) |
PL (1) | PL174806B1 (en) |
SI (1) | SI9400029A (en) |
SK (1) | SK279839B6 (en) |
WO (1) | WO1994016691A1 (en) |
YU (1) | YU48663B (en) |
ZA (1) | ZA94415B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8410131B2 (en) | 2001-02-19 | 2013-04-02 | Novartis Pharmaceuticals Corporation | Cancer treatment |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19814084B4 (en) * | 1998-03-30 | 2005-12-22 | Lts Lohmann Therapie-Systeme Ag | D2 agonist-containing transdermal therapeutic system for the treatment of Parkinson's syndrome and process for its preparation |
ES2244422T3 (en) * | 1999-04-01 | 2005-12-16 | Alza Corporation | DEVICES FOR THE TRANSDERMAL ADMINISTRATION OF PHARMACOS THAT INCLUDE A POLYURETHANE DEPOSIT FOR PHARMACOS. |
DE10234673B4 (en) * | 2002-07-30 | 2007-08-16 | Schwarz Pharma Ag | Hot-melt TTS for the administration of rotigotine and process for its preparation, and use of rotigotine in the manufacture of a hot-melt TTS |
US8246980B2 (en) * | 2002-07-30 | 2012-08-21 | Ucb Pharma Gmbh | Transdermal delivery system |
US8246979B2 (en) | 2002-07-30 | 2012-08-21 | Ucb Pharma Gmbh | Transdermal delivery system for the administration of rotigotine |
US8211462B2 (en) * | 2002-07-30 | 2012-07-03 | Ucb Pharma Gmbh | Hot-melt TTS for administering rotigotine |
DE60204229T2 (en) * | 2002-12-02 | 2006-02-02 | Schwarz Pharma Ag | Administration of rotigotine for the treatment of Parkinson's disease by iontophoresis |
DE10261696A1 (en) | 2002-12-30 | 2004-07-15 | Schwarz Pharma Ag | Device for the transdermal administration of rotigotine base |
EP2921184A1 (en) * | 2014-03-19 | 2015-09-23 | LTS LOHMANN Therapie-Systeme AG | Finishing plaster having improved tolerability and a long adhesive period and method for producing the same |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3315245A1 (en) * | 1983-04-27 | 1984-10-31 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmaceutical product |
EP0204968A1 (en) * | 1985-05-24 | 1986-12-17 | Beiersdorf Aktiengesellschaft | Nitroglycerine dressing |
EP0251425A1 (en) * | 1986-04-03 | 1988-01-07 | Hercon Laboratories Corporation | Article for administration of pharmacologically-active substances |
EP0305758A1 (en) * | 1987-09-01 | 1989-03-08 | LTS Lohmann Therapie-Systeme GmbH & Co. KG | Method for the preparation of a patch for the transdermal sustained release of nitroglycerine |
EP0384267A2 (en) * | 1989-02-18 | 1990-08-29 | LTS Lohmann Therapie-Systeme GmbH & Co. KG | Therapeutic system for the sustained and controlled transdermal or transmucosal delivery of active agents |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3742951A (en) * | 1971-08-09 | 1973-07-03 | Alza Corp | Bandage for controlled release of vasodilators |
FR2435950A1 (en) * | 1978-06-05 | 1980-04-11 | Riker Laboratories Inc | MEDICAL DRESSING COMPRISING A NITROGLYCERIN COMPOSITION, ITS MANUFACTURE AND ITS APPLICATION |
US4725272A (en) * | 1981-06-29 | 1988-02-16 | Alza Corporation | Novel bandage for administering beneficial drug |
DE3315272C2 (en) * | 1983-04-27 | 1986-03-27 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmaceutical product and process for its manufacture |
US4701509A (en) * | 1984-09-17 | 1987-10-20 | Johnson & Johnson Products, Inc. | N-vinyl caprolactam-containing hot melt adhesives |
US4666441A (en) * | 1985-12-17 | 1987-05-19 | Ciba-Geigy Corporation | Multicompartmentalized transdermal patches |
CH672888A5 (en) * | 1986-11-07 | 1990-01-15 | Mepha Ag | |
US5273757A (en) * | 1987-09-01 | 1993-12-28 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Apparatus for the delivery of substances, processes for the production thereof and use thereof |
US5306502A (en) * | 1987-09-01 | 1994-04-26 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Apparatus for delivering nitroglycerin to the skin, processes for the production thereof and the use thereof |
DE3743945A1 (en) * | 1987-09-01 | 1989-03-09 | Lohmann Gmbh & Co Kg | DEVICE FOR DELIVERING SUBSTANCES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE |
-
1993
- 1993-01-23 DE DE4301781A patent/DE4301781C2/en not_active Expired - Fee Related
- 1993-12-30 IL IL10823393A patent/IL108233A/en active IP Right Grant
-
1994
- 1994-01-10 AT AT94904650T patent/ATE149829T1/en not_active IP Right Cessation
- 1994-01-10 EP EP94904650A patent/EP0680319B1/en not_active Expired - Lifetime
- 1994-01-10 PL PL94309602A patent/PL174806B1/en unknown
- 1994-01-10 ES ES94904650T patent/ES2102199T3/en not_active Expired - Lifetime
- 1994-01-10 CA CA002153571A patent/CA2153571A1/en not_active Abandoned
- 1994-01-10 JP JP6516613A patent/JPH08505631A/en active Pending
- 1994-01-10 AU AU58606/94A patent/AU687775B2/en not_active Ceased
- 1994-01-10 KR KR1019950703007A patent/KR960700049A/en active IP Right Grant
- 1994-01-10 CZ CZ951841A patent/CZ284899B6/en unknown
- 1994-01-10 SK SK891-95A patent/SK279839B6/en unknown
- 1994-01-10 NZ NZ259710A patent/NZ259710A/en unknown
- 1994-01-10 US US08/492,004 patent/US5670164A/en not_active Expired - Fee Related
- 1994-01-10 HU HU9501966A patent/HU220768B1/en unknown
- 1994-01-10 WO PCT/EP1994/000053 patent/WO1994016691A1/en active IP Right Grant
- 1994-01-10 DE DE59402070T patent/DE59402070D1/en not_active Expired - Fee Related
- 1994-01-10 DK DK94904650.2T patent/DK0680319T3/en active
- 1994-01-17 MY MYPI94000114A patent/MY110391A/en unknown
- 1994-01-19 PH PH47632A patent/PH31559A/en unknown
- 1994-01-20 ZA ZA94415A patent/ZA94415B/en unknown
- 1994-01-20 HR HRP4301781.9A patent/HRP940030B1/en not_active IP Right Cessation
- 1994-01-21 SI SI9400029A patent/SI9400029A/en unknown
- 1994-01-21 YU YU2594A patent/YU48663B/en unknown
-
1995
- 1995-07-21 NO NO952908A patent/NO952908L/en not_active Application Discontinuation
- 1995-07-21 FI FI953532A patent/FI953532A0/en unknown
-
1997
- 1997-05-21 GR GR970401155T patent/GR3023505T3/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3315245A1 (en) * | 1983-04-27 | 1984-10-31 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmaceutical product |
EP0204968A1 (en) * | 1985-05-24 | 1986-12-17 | Beiersdorf Aktiengesellschaft | Nitroglycerine dressing |
EP0251425A1 (en) * | 1986-04-03 | 1988-01-07 | Hercon Laboratories Corporation | Article for administration of pharmacologically-active substances |
EP0305758A1 (en) * | 1987-09-01 | 1989-03-08 | LTS Lohmann Therapie-Systeme GmbH & Co. KG | Method for the preparation of a patch for the transdermal sustained release of nitroglycerine |
EP0384267A2 (en) * | 1989-02-18 | 1990-08-29 | LTS Lohmann Therapie-Systeme GmbH & Co. KG | Therapeutic system for the sustained and controlled transdermal or transmucosal delivery of active agents |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8410131B2 (en) | 2001-02-19 | 2013-04-02 | Novartis Pharmaceuticals Corporation | Cancer treatment |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE4002281C2 (en) | ||
DE4400770C1 (en) | Plaster containing an active substance for delivery of oestradiol with at least one penetration enhancer, method of producing it and its use | |
EP0305758B1 (en) | Method for the preparation of a patch for the transdermal sustained release of nitroglycerine | |
EP0697860B1 (en) | Transdermal therapeutic system containing estradiol | |
EP0617972B1 (en) | Dermal therapeutic system based on a mixture of fusible polymethacrylates | |
EP1003490B1 (en) | Transdermal therapeutic system (tts) for administering sexual steroid hormones | |
DE19728516C2 (en) | TTS for administration of levonorgestrel and possibly estradiol | |
EP0659081B1 (en) | Dexpanthenol-containing plaster for the transdermal application of steroid hormones | |
DE10234673A1 (en) | Hot melt TTS for administration of rotigotine | |
DE19837902A1 (en) | Transdermal patch | |
EP2111857A1 (en) | Transdermal therapeutic system for application of fentanyl or an analogue material thereof | |
EP0261402A1 (en) | Transcutaneous therapeutic device; use and preparation thereof | |
DE102006054733A1 (en) | Transdermal therapeutic system with high drug utilization rate and dosing accuracy | |
WO1994016691A1 (en) | Nitroglycerine-containing plaster, process for producing the same and its use | |
DE10118282A1 (en) | Pressure sensitive adhesive based on ethylene-vinyl acetate copolymers and adhesive resins, for medical purposes | |
WO2015139830A1 (en) | Over-patch having improved compatibility and a long adhesion duration and method for producing said over-patch | |
EP1480625A1 (en) | Transdermal system comprising fentanyl | |
DD290581A5 (en) | METHOD FOR PRODUCING A TRANSDERMAL THERAPEUTIC SYSTEM WITH NORPSEUDOEPHEDRINE AS AN ACTIVE INGREDIENT | |
EP2614820A1 (en) | Transdermal therapeutic system with a choline esterase inhibitor | |
EP3651744B1 (en) | Fampridine tts | |
DE102018216244A1 (en) | Transdermal therapeutic system with barrier layer | |
DE102018118507A1 (en) | Transdermal therapeutic system for the delivery of scopolamine without a membrane |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA CZ FI HU JP KR NO NZ PL SK US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2153571 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 89195 Country of ref document: SK |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV1995-1841 Country of ref document: CZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 259710 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 953532 Country of ref document: FI |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1994904650 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08492004 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1994904650 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: PV1995-1841 Country of ref document: CZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 1994904650 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: PV1995-1841 Country of ref document: CZ |